<?xml version="1.0" encoding="UTF-8"?>
<p>It is estimated that 
 <italic>C. sativa</italic> produces an estimated 545 [
 <xref rid="B26-molecules-26-00607" ref-type="bibr">26</xref>] chemical compounds belonging to biogenetic classes [
 <xref rid="B27-molecules-26-00607" ref-type="bibr">27</xref>]. Of these compounds, the two most prominent and most studied are the secondary metabolites (phytocannabinoids)—Δ
 <sup>9</sup>-tetrahydrocannabinol (Δ
 <sup>9</sup>-THC) and cannabidiol (CBD), both of which have a wide therapeutic window against many ailments. In addition to these secondary metabolites, 
 <italic>C. sativa</italic> produces hundreds of non-cannabinoids secondary metabolites, also with a wide range of therapeutic applicability against many ailments. These include terpenoids, flavonoids, stilbenes, lignans, and alkaloids [
 <xref rid="B28-molecules-26-00607" ref-type="bibr">28</xref>]. Some of these phytochemicals have antiviral activity. Dihydro-resveratrol, a metabolite of trans-resveratrol, an antiviral found in grapes, is also found in cannabis [
 <xref rid="B27-molecules-26-00607" ref-type="bibr">27</xref>]. Terpenes like limonene and ocimene have also been reported to demonstrate antiviral activity [
 <xref rid="B29-molecules-26-00607" ref-type="bibr">29</xref>,
 <xref rid="B30-molecules-26-00607" ref-type="bibr">30</xref>]. A 2020 study by Ngwa and colleagues reported that a small antiviral flavonoid molecule Caflanone has selective activity against the human coronavirus hCov-OC43 (COVID-19) disease [
 <xref rid="B31-molecules-26-00607" ref-type="bibr">31</xref>].
</p>
